We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The relationship between anemia, liver disease, and hepcidin levels in hemodialysis patients with hepatitis.
- Authors
Zumrutdal, A; Sezgin, N
- Abstract
We investigated the role of hepcidin in ameliorating anemia in hemodialysis patients with hepatitis. A total of 72 hemodialysis patients with hepatitis were classified according to their requirement of erythropoietin (EPO). Anemia parameters, C-reactive protein (CRP), and biochemical measurements were recorded along with the hepcidin. The number of patients receiving no EPO was higher among patients with liver disease when compared with those without liver disease (P = 0.002). The mean hepcidin levels of the patients who did not receive EPO did not differ statistically from those of the patients who received the maximum dose (P = 0.5). The hepcidin levels of patients with liver disease who received no EPO were lower compared to those patients without liver disease who received the maximum dose (P = 0.04). There was a positive correlation between hepcidin and mean platelet levels (r = 0.26, P = 0.027) and annual intravenous iron dose (r = 0.31, P = 0.007). In hemodialysis patients with hepatitis, liver disease may be one of the factors affecting erythropiesis, related with decreased hepcidin levels and iron hemostasis. Further studies are needed to verify these associations.
- Publication
Indian journal of nephrology, 2012, Vol 22, Issue 6, p415
- ISSN
0971-4065
- Publication type
Journal Article
- DOI
10.4103/0971-4065.106031